Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates

Nature Biotechnology

Volumn 34, Issue 3, 2016, Pages 345-352

  Vegas, Arturo J ^a,b,g   Veiseh, Omid ^a,c   Doloff, Joshua C ^a,b   Ma, Minglin ^a,b,h   Tam, Hok Hei ^a,c   Bratlie, Kaitlin ^a,c,i   Li, Jie ^a,b   Bader, Andrew R ^a,b,c   Langan, Erin ^a,b   Olejnik, Karsten ^a,b   Fenton, Patrick ^a,b   Kang, Jeon Woong ^a   Hollister Locke, Jennifer ^d   Bochenek, Matthew A ^e   Chiu, Alan ^a,b   Siebert, Sean ^a,b   Tang, Katherine ^a,b   Jhunjhunwala, Siddharth ^a,b   Aresta Dasilva, Stephanie ^a,b   Dholakia, Nimit ^a,b   Thakrar, Raj ^a,b   Vietti, Thema ^a,b   Chen, Michael ^a,b   Cohen, Josh ^d   Siniakowicz, Karolina ^d   Qi, Meirigeng ^e   McGarrigle, James ^e   Lyle, Stephen ^f   Harlan, David M ^f   Greiner, Dale L ^f   Oberholzer, Jose ^e   Weir, Gordon C ^d   Langer, Robert ^a,b,c   Anderson, Daniel G ^a,b,c   more..

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g Boston University   (United States)

^h Department of Biological and Environmental Engineering   (United States)

ⁱ Iowa State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL EQUIPMENT; CHEMICAL MODIFICATION; HYDROGELS; MAMMALS; NITROGEN COMPOUNDS;

COMBINATORIAL APPROACH; COVALENT CHEMICAL MODIFICATION; FOREIGN BODY REACTIONS; FOREIGN BODY RESPONSE; HYDROGEL SURFACES; IMPLANTED MEDICAL DEVICES; MEDIATED REACTIONS; NON-HUMAN PRIMATE;

IMPLANTS (SURGICAL);

ALGINIC ACID; BIOMATERIAL; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CHEMICAL MODIFICATION; COMBINATORIAL LIBRARY; CONTROLLED STUDY; DEVICE MATERIAL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FOREIGN BODY REACTION; HYDROGEL; MACROPHAGE; MICROCAPSULE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; ADVERSE EFFECTS; ANIMAL; FOREIGN BODY; HUMAN; IMMUNOLOGY; PROSTHESES AND ORTHOSES; THERAPEUTIC USE;

ANIMALS; BIOCOMPATIBLE MATERIALS; FOREIGN BODIES; FOREIGN-BODY REACTION; HUMANS; HYDROGELS; MACROPHAGES; PRIMATES; PROSTHESES AND IMPLANTS;

EID: 84958141123     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3462     Document Type: Article

References (56)

1. Anderson, J.M., Rodriguez, A. & Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol. 20, 86-100 (2008).
2. Langer, R. Perspectives and challenges in tissue engineering and regenerative medicine. Adv. Mater. 21, 3235-3236 (2009).
3. Ward, W.K. A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J. Diabetes Sci. Technol. 2, 768-777 (2008).
4. Harding, J.L. & Reynolds, M.M. Combating medical device fouling. Trends Biotechnol. 32, 140-146 (2014).
5. Grainger, D.W. All charged up about implanted biomaterials. Nat. Biotechnol. 31, 507-509 (2013).
6. Williams, D.F. On the mechanisms of biocompatibility. Biomaterials 29, 2941-2953 (2008).
7. Wick, G. et al. The immunology of fibrosis. Annu. Rev. Immunol. 31, 107-135 (2013).
8. Wynn, T.A. & Ramalingam, T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028-1040 (2012).
9. Zhang, L. et al. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat. Biotechnol. 31, 553-556 (2013).
10. Sussman, E.M., Halpin, M.C., Muster, J., Moon, R.T. & Ratner, B.D. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction. Ann. Biomed. Eng. 42, 1508-1516 (2013).
11. Rodriguez, A., Meyerson, H. & Anderson, J.M. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J. Biomed. Mater. Res. A 89, 152-159 (2009).
12. Hetrick, E.M., Prichard, H.L., Klitzman, B. & Schoenfisch, M.H. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 28, 4571-4580 (2007).
13. Ratner, B.D. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J. Control. Release 78, 211-218 (2002).
14. Lee, K.Y. & Mooney, D.J. Alginate: properties and biomedical applications. Prog. Polym. Sci. 37, 106-126 (2012).
15. Kearney, C.J. & Mooney, D.J. Macroscale delivery systems for molecular and cellular payloads. Nat. Mater. 12, 1004-1017 (2013).
16. Lim, F. & Sun, A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908-910 (1980).
17. Duvivier-Kali, V.F., Omer, A., Parent, R.J., O'Neil, J.J. & Weir, G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50, 1698-1705 (2001).
18. de Vos, P., Faas, M.M., Strand, B. & Calafiore, R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27, 5603-5617 (2006).
19. Tuch, B.E. et al. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 32, 1887-1889 (2009).
20. Weir, G.C. Islet encapsulation: advances and obstacles. Diabetologia 56, 1458-1461 (2013).
21. Jacobs-Tulleneers-Thevissen, D. et al. Beta Cell Therapy Consortium EU-FP7. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 56, 1605-1614 (2013).
22. Scharp, D.W. & Marchetti, P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv. Drug Deliv. Rev. 67-68, 35-73 (2014).
23. Robitaille, R. et al. Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules. Biomaterials 26, 4119-4127 (2005).
24. Dang, T.T. et al. Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. Biomaterials 34, 5792-5801 (2013).
25. Rokstad, A.M. et al. Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater. 7, 2566-2578 (2011).
26. King, A., Sandler, S. & Andersson, A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J. Biomed. Mater. Res. 57, 374-383 (2001).
27. Manoury, B., Caulet-Maugendre, S., Guénon, I., Lagente, V. & Boichot, E. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int. J. Immunopathol. Pharmacol. 19, 471-487 (2006).
28. Brocchini, S., James, K., Tangpasuthadol, V. & Kohn, J. Structure-property correlations in a combinatorial library of degradable biomaterials. J. Biomed. Mater. Res. 42, 66-75 (1998).
29. Gu, M. et al. Combinatorial synthesis with high throughput discovery of protein-resistant membrane surfaces. Biomaterials 34, 6133-6138 (2013).
30. Bratlie, K.M. et al. Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One 5, e10032 (2010).
31. Christen, T. et al. Molecular imaging of innate immune cell function in transplant rejection. Circulation 119, 1925-1932 (2009).
32. Haller, J. et al. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J. Appl. Physiol. 104, 795-802 (2008).
33. Omer, A. et al. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 52, 69-75 (2003).
34. Omer, A. et al. Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 79, 52-58 (2005).
35. Veiseh, O. et al. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat. Mater. 14, 643-651 (2015).
36. Hofman, K., Hall, B., Cleaver, H. & Marshall, S. High-throughput quantification of hydroxyproline for determination of collagen. Anal. Biochem. 417, 289-291 (2011).
37. Paredes-Juarez, G.A., de Haan, B.J., Faas, M.M. & de Vos, P. A technology platform to test the efficacy of purification of alginate. Materials (Basel) 7, 2087-2103 (2014).
38. Paredes-Juarez, G.A., de Haan, B.J., Faas, M.M. & de Vos, P. The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules. J. Control. Release 172, 983-992 (2013).
39. Sato, M. et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 171, 417-425 (2003).
40. de Vos, P. et al. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 30, 2559-2570 (2009).
41. Orive, G., Tam, S.K., Pedraz, J.L. & Hallé, J.P. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials 27, 3691-3700 (2006).
42. Dusseault, J. et al. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J. Biomed. Mater. Res. A 76, 243-251 (2006).
43. Ménard, M. et al. Role of protein contaminants in the immunogenicity of alginates. J. Biomed. Mater. Res. B Appl. Biomater. 93, 333-340 (2010).
44. Madden, L.R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl. Acad. Sci. USA 107, 15211-15216 (2010).
45. Brauker, J.H. et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 29, 1517-1524 (1995).
46. Liu, M. et al. Stabilized hemocompatible coating of nitinol devices based on photo-cross-linked alginate/heparin multilayer. Langmuir 23, 9378-9385 (2007).
47. Kim, K., Cheng, J., Liu, Q., Wu, X.Y. & Sun, Y. Investigation of mechanical properties of soft hydrogel microcapsules in relation to protein delivery using a MEMS force sensor. J. Biomed. Mater. Res. A 92, 103-113 (2010).
48. de Haan, B.J. et al. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid. J. Biomed. Mater. Res. A 98, 394-403 (2011).
49. Qi, M. et al. A recommended laparoscopic procedure for implantation of microcapsules in the peritoneal cavity of non-human primates. J. Surg. Res. 168, e117-e123 (2011).
50. Kharb, R., Sharma, P.C. & Yar, M.S. Pharmacological significance of triazole scaffold. J. Enzyme Inhib. Med. Chem. 26, 1-21 (2011).
51. Lindstedt, R. et al. The immunosuppressor st1959, a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency. Int. J. Immunopathol. Pharmacol. 22, 29-42 (2009).
52. Vegas, A.J. et al. Long term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat. Med. doi:10.1038/nm.4030 (25 January 2016).
53. Stoppel, W.L. et al. Terminal sterilization of alginate hydrogels: efficacy and impact on mechanical properties. J. Biomed. Mater. Res. B Appl. Biomater. 102, 877-884 (2014).
54. Bernhardt, A. et al. Improved sterilization of sensitive biomaterials with supercritical carbon dioxide at low temperature. PLoS One 10, e0129205 (2015).
55. Kang, J.W. et al. Combined confocal Raman and quantitative phase microscopy system for biomedical diagnosis. Biomed. Opt. Express 2, 2484-2492 (2011).
56. Kang, J.W., Nguyen, F.T., Lue, N., Dasari, R.R. & Heller, D.A. Measuring uptake dynamics of multiple identifiable carbon nanotube species via high-speed confocal Raman imaging of live cells. Nano Lett. 12, 6170-6174 (2012).